Mark P. Clein

Mark Clein is the Co-Founder and CEO of Precision Medicine Group. He has over 20 years of experience in the healthcare industry. Prior to Precision, Mr. Clein was Co-Founder, President and CFO of United BioSource Corporation (UBC), which became the leader in real-world research addressing safety, value, and comparative effectiveness for the life science industry. UBC was acquired by Medco Health Solutions in late 2010 and is now part of Express Scripts. Prior to UBC, Clein was Founder and CFO of U.S. Bioservices, a leading provider of distribution services for specialty pharmaceuticals and biologics. Clein also served as Chief Executive Officer of PMR Corporation, a leading provider of outpatient services for psychiatric and central nervous system disorders. In 2002, PMR merged with Psychiatric Solutions, Inc., which grew into the largest US provider of psychiatric inpatient services. Clein served on its board of directors until the company’s acquisition by Universal Health Systems in 2010. He received his Master of Business Administration degree from the Columbia Graduate School of Business and his undergraduate degree from the University of North Carolina. Clein also serves on the Arts and Sciences Foundation Board at the University of North Carolina.